Scot Harper
Chief Tech/Sci/R&D Officer at RADIOPHARM THERANOSTICS LIMITED
Profile
Scot L.
Harper is currently the Senior Vice President-Clinical Operations at Radiopharm Theranostics Ltd.
Previously, he worked as the Vice President-Clinical Operations at Endocyte, Inc. from 2013 to 2016.
Harper received his undergraduate degree from DePauw University, his graduate degree from the University of South Alabama, and his doctorate from The Indiana University School of Medicine.
Scot Harper active positions
| Companies | Position | Start |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 2021-11-30 |
Former positions of Scot Harper
| Companies | Position | End |
|---|---|---|
| ENDOCYTE, INC. | Chief Tech/Sci/R&D Officer | 2016-10-27 |
Training of Scot Harper
| University of South Alabama | Graduate Degree |
| DePauw University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Private companies | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Stock Market
- Insiders
- Scot Harper
